GSK logo

GSK (GSK) Operating profit

annual operating profit:

$5.14B-$4.00B(-43.77%)
December 31, 2024

Summary

  • As of today (June 11, 2025), GSK annual operating income is $5.14 billion, with the most recent change of -$4.00 billion (-43.77%) on December 31, 2024.
  • During the last 3 years, GSK annual operating profit has fallen by -$1.57 billion (-23.42%).
  • GSK annual operating profit is now -68.69% below its all-time high of $16.41 billion, reached on December 31, 2007.

Performance

GSK Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

quarterly operating profit:

$2.79B-$48.21M(-1.70%)
March 31, 2025

Summary

  • As of today (June 11, 2025), GSK quarterly operating income is $2.79 billion, with the most recent change of -$48.21 million (-1.70%) on March 31, 2025.
  • Over the past year, GSK quarterly operating profit has increased by +$900.35 million (+47.64%).
  • GSK quarterly operating profit is now -80.03% below its all-time high of $13.97 billion, reached on March 31, 2015.

Performance

GSK quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

TTM operating profit:

$7.95B+$900.35M(+12.77%)
March 31, 2025

Summary

  • As of today (June 11, 2025), GSK TTM operating income is $7.95 billion, with the most recent change of +$900.35 million (+12.77%) on March 31, 2025.
  • Over the past year, GSK TTM operating profit has dropped by -$543.10 million (-6.39%).
  • GSK TTM operating profit is now -58.74% below its all-time high of $19.27 billion, reached on March 31, 2015.

Performance

GSK TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

GSK Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-43.8%+47.6%-6.4%
3 y3 years-23.4%-9.3%-2.2%
5 y5 years-36.0%+8.1%-9.7%

GSK Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-43.8%at low-9.3%+1034.6%-22.2%+40.3%
5 y5-year-43.8%at low-21.1%+198.6%-23.2%+149.3%
alltimeall time-68.7%>+9999.0%-80.0%+123.1%-58.7%+182.4%

GSK Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$2.79B(-1.7%)
$7.95B(+12.8%)
Dec 2024
$5.14B(-43.8%)
$2.84B(+1054.2%)
$7.05B(+24.4%)
Sep 2024
-
$245.93M(-88.2%)
$5.67B(-28.2%)
Jun 2024
-
$2.08B(+9.9%)
$7.89B(-7.1%)
Mar 2024
-
$1.89B(+29.7%)
$8.49B(-7.0%)
Dec 2023
$9.14B(+9.7%)
$1.46B(-41.0%)
$9.14B(-10.6%)
Sep 2023
-
$2.47B(-7.9%)
$10.22B(+11.6%)
Jun 2023
-
$2.68B(+5.9%)
$9.16B(+16.9%)
Mar 2023
-
$2.53B(-0.5%)
$7.84B(-6.5%)
Dec 2022
$8.33B(+24.2%)
$2.54B(+81.5%)
$8.38B(+16.4%)
Sep 2022
-
$1.40B(+3.1%)
$7.20B(-6.5%)
Jun 2022
-
$1.36B(-55.8%)
$7.70B(-5.2%)
Mar 2022
-
$3.08B(+125.3%)
$8.13B(+10.1%)
Dec 2021
$6.71B(+14.2%)
$1.37B(-28.2%)
$7.38B(+131.5%)
Sep 2021
-
$1.90B(+6.8%)
$3.19B(-13.5%)
Jun 2021
-
$1.78B(-23.6%)
$3.69B(-32.2%)
Mar 2021
-
$2.33B(-182.5%)
$5.44B(-4.4%)
Dec 2020
$5.88B(-26.9%)
-$2.83B(-217.8%)
$5.69B(-43.7%)
Sep 2020
-
$2.40B(-32.0%)
$10.11B(-2.3%)
Jun 2020
-
$3.53B(+36.9%)
$10.35B(+17.6%)
Mar 2020
-
$2.58B(+62.5%)
$8.80B(+8.9%)
Dec 2019
$8.03B(-14.7%)
$1.59B(-40.0%)
$8.08B(-6.4%)
Sep 2019
-
$2.65B(+33.1%)
$8.64B(-0.1%)
Jun 2019
-
$1.99B(+6.9%)
$8.64B(+12.0%)
Mar 2019
-
$1.86B(-13.2%)
$7.71B(-5.6%)
Dec 2018
$9.42B(+20.4%)
$2.14B(-19.2%)
$8.18B(-12.4%)
Sep 2018
-
$2.65B(+149.7%)
$9.33B(+2.1%)
Jun 2018
-
$1.06B(-54.3%)
$9.14B(-4.4%)
Mar 2018
-
$2.32B(-29.7%)
$9.56B(+4.5%)
Dec 2017
$7.83B(-4.2%)
$3.30B(+34.4%)
$9.15B(-15.6%)
Sep 2017
-
$2.46B(+65.7%)
$10.85B(+5.6%)
Jun 2017
-
$1.48B(-22.3%)
$10.27B(+19.8%)
Mar 2017
-
$1.91B(-61.8%)
$8.57B(+11.4%)
Dec 2016
$8.16B(+103.3%)
$5.00B(+165.9%)
$7.69B(-182.2%)
Sep 2016
-
$1.88B(-966.6%)
-$9.36B(-3.0%)
Jun 2016
-
-$216.90M(-121.0%)
-$9.65B(+8.2%)
Mar 2016
-
$1.03B(-108.6%)
-$8.92B(-322.1%)
Dec 2015
$4.02B(-43.4%)
-$12.06B(-859.0%)
$4.02B(-78.0%)
Sep 2015
-
$1.59B(+209.5%)
$18.29B(+2.3%)
Jun 2015
-
$513.14M(-96.3%)
$17.87B(-7.3%)
Mar 2015
-
$13.97B(+530.7%)
$19.27B(+172.7%)
Dec 2014
$7.10B(-22.9%)
$2.21B(+88.7%)
$7.07B(+1.6%)
Sep 2014
-
$1.17B(-38.7%)
$6.95B(-15.3%)
Jun 2014
-
$1.91B(+8.5%)
$8.21B(-3.5%)
Mar 2014
-
$1.76B(-16.1%)
$8.51B(-7.5%)
Dec 2013
$9.21B(-4.3%)
$2.10B(-13.6%)
$9.20B(-3.8%)
Sep 2013
-
$2.43B(+10.1%)
$9.56B(+3.1%)
Jun 2013
-
$2.21B(-10.0%)
$9.27B(-0.1%)
Mar 2013
-
$2.45B(-0.4%)
$9.28B(-3.5%)
Dec 2012
$9.62B(-20.4%)
$2.46B(+15.0%)
$9.62B(-0.8%)
Sep 2012
-
$2.14B(-3.6%)
$9.70B(-11.5%)
Jun 2012
-
$2.22B(-20.4%)
$10.96B(-5.8%)
Mar 2012
-
$2.79B(+10.0%)
$11.64B(-0.6%)
Dec 2011
$12.10B(+117.3%)
$2.54B(-25.5%)
$11.71B(+30.3%)
Sep 2011
-
$3.41B(+17.5%)
$8.99B(+6.1%)
Jun 2011
-
$2.90B(+1.1%)
$8.47B(+53.3%)
Mar 2011
-
$2.87B(-1638.3%)
$5.52B(-1.6%)
Dec 2010
$5.57B(-57.8%)
-$186.40M(-106.5%)
$5.61B(-42.7%)
Sep 2010
-
$2.89B(-6553.3%)
$9.79B(-5.0%)
Jun 2010
-
-$44.72M(-101.5%)
$10.30B(-25.1%)
Mar 2010
-
$2.95B(-26.1%)
$13.76B(+4.3%)
Dec 2009
$13.20B(-0.1%)
$4.00B(+17.7%)
$13.19B(+13.0%)
Sep 2009
-
$3.40B(-0.4%)
$11.67B(+2.3%)
Jun 2009
-
$3.41B(+43.1%)
$11.40B(-3.5%)
Mar 2009
-
$2.38B(-3.7%)
$11.81B(-11.3%)
Dec 2008
$13.21B(-19.5%)
$2.48B(-21.0%)
$13.31B(-13.1%)
Sep 2008
-
$3.13B(-18.1%)
$15.33B(+24.6%)
Jun 2008
-
$3.82B(-1.5%)
$12.30B(+3.2%)
Mar 2008
-
$3.88B(-13.5%)
$11.91B(-2.9%)
Dec 2007
$16.41B(+14.0%)
$4.49B(+4185.0%)
$12.27B(+11.2%)
Sep 2007
-
$104.74M(-97.0%)
$11.03B(-25.0%)
Jun 2007
-
$3.44B(-18.8%)
$14.72B(-0.4%)
Mar 2007
-
$4.23B(+30.1%)
$14.78B(+3.0%)
Dec 2006
$14.39B(+2074.0%)
$3.25B(-14.2%)
$14.35B(+458.3%)
Sep 2006
-
$3.79B(+8.4%)
$2.57B(+30.4%)
Jun 2006
-
$3.50B(-8.2%)
$1.97B(+19.8%)
Mar 2006
-
$3.81B(-144.7%)
$1.65B(+44.0%)
Dec 2005
$661.92M(-93.7%)
-$8.52B(-367.0%)
$1.14B(-90.5%)
Sep 2005
-
$3.19B(+0.7%)
$11.98B(+4.1%)
Jun 2005
-
$3.17B(-4.0%)
$11.51B(+3.7%)
Mar 2005
-
$3.30B(+42.9%)
$11.09B(+5.3%)
DateAnnualQuarterlyTTM
Dec 2004
$10.54B(+1.0%)
$2.31B(-15.2%)
$10.53B(+132.3%)
Sep 2004
-
$2.72B(-1.1%)
$4.54B(+17.5%)
Jun 2004
-
$2.76B(+0.5%)
$3.86B(-61.9%)
Mar 2004
-
$2.74B(-174.4%)
$10.13B(+0.2%)
Dec 2003
$10.44B(+3.8%)
-$3.69B(-279.8%)
$10.11B(+2.4%)
Sep 2003
-
$2.05B(-77.3%)
$9.87B(-17.6%)
Jun 2003
-
$9.02B(+231.0%)
$11.97B(+18.3%)
Mar 2003
-
$2.72B(-169.4%)
$10.12B(+4.4%)
Dec 2002
$10.06B(+14.4%)
-$3.93B(-194.5%)
$9.69B(-14.0%)
Sep 2002
-
$4.15B(-42.0%)
$11.27B(+6.4%)
Jun 2002
-
$7.17B(+212.0%)
$10.59B(+40.4%)
Mar 2002
-
$2.30B(-197.9%)
$7.54B(-14.0%)
Dec 2001
$8.79B(+69.5%)
-$2.35B(-167.6%)
$8.77B(+50.5%)
Sep 2001
-
$3.47B(-15.7%)
$5.83B(+1.1%)
Jun 2001
-
$4.12B(+16.7%)
$5.77B(+6.9%)
Mar 2001
-
$3.53B(-166.7%)
$5.40B(-3.5%)
Dec 2000
$5.19B(+14.5%)
-$5.29B(-255.1%)
$5.60B(+5.1%)
Sep 2000
-
$3.41B(-9.0%)
$5.32B(-4.2%)
Jun 2000
-
$3.75B(+0.6%)
$5.56B(+91.5%)
Mar 2000
-
$3.73B(-167.0%)
$2.90B(+17.9%)
Dec 1999
$4.53B(+3.0%)
-$5.56B(-252.6%)
$2.46B(-3.5%)
Sep 1999
-
$3.65B(+233.8%)
$2.55B(+10.6%)
Jun 1999
-
$1.09B(-66.8%)
$2.31B(+3.7%)
Mar 1999
-
$3.29B(-160.1%)
$2.23B(+5.1%)
Dec 1998
$4.40B(-7.3%)
-$5.47B(-260.9%)
$2.12B(-4.0%)
Sep 1998
-
$3.40B(+236.4%)
$2.21B(+7.1%)
Jun 1998
-
$1.01B(-68.2%)
$2.06B(-52.5%)
Mar 1998
-
$3.18B(-159.1%)
$4.34B(-3.5%)
Dec 1997
$4.75B(-2.8%)
-$5.38B(-265.5%)
$4.50B(-34.3%)
Sep 1997
-
$3.25B(-1.1%)
$6.85B(-8.2%)
Jun 1997
-
$3.29B(-1.4%)
$7.47B(+1.4%)
Mar 1997
-
$3.34B(-210.1%)
$7.36B(+1.1%)
Dec 1996
$4.88B(-13.3%)
-$3.03B(-178.4%)
$7.28B(-29.4%)
Sep 1996
-
$3.87B(+21.3%)
$10.31B(+14.5%)
Jun 1996
-
$3.19B(-2.1%)
$9.01B(+1745.6%)
Mar 1996
-
$3.26B(+27.0%)
$488.17M(-79.4%)
Dec 1995
$5.63B(+145.6%)
-
-
Sep 1995
-
$2.56B(-148.1%)
$2.37B(+1.4%)
Jun 1995
-
-$5.33B(-310.9%)
$2.34B(-39.5%)
Jun 1995
$2.29B(-15.4%)
-
-
Mar 1995
-
$2.53B(-3.3%)
$3.87B(+7.4%)
Dec 1994
-
$2.61B(+3.3%)
$3.60B(+15.9%)
Sep 1994
-
$2.53B(-166.5%)
$3.11B(+16.4%)
Jun 1994
$2.71B(+9.8%)
-$3.80B(-268.3%)
$2.67B(-8.5%)
Mar 1994
-
$2.26B(+6.6%)
$2.92B(+1.1%)
Dec 1993
-
$2.12B(+1.3%)
$2.89B(+12.1%)
Sep 1993
-
$2.09B(-158.9%)
$2.57B(+9.9%)
Jun 1993
$2.47B(+8.6%)
-$3.56B(-259.6%)
$2.34B(+8.2%)
Mar 1993
-
$2.23B(+23.3%)
$2.16B(+12.9%)
Dec 1992
-
$1.81B(-2.9%)
$1.92B(-2.1%)
Sep 1992
-
$1.86B(-149.8%)
$1.96B(-0.6%)
Jun 1992
$2.27B(>+9900.0%)
-$3.74B(-288.5%)
$1.97B(+20.2%)
Mar 1992
-
$1.98B(+7.2%)
$1.64B(+40.1%)
Dec 1991
-
$1.85B(-1.3%)
$1.17B(+64.4%)
Sep 1991
-
$1.87B(-146.1%)
$711.22M(+242.0%)
Jun 1991
$0.00(0.0%)
-$4.07B(-368.8%)
$207.96M(-58.2%)
Mar 1991
-
$1.51B(+8.7%)
$497.92M(+75.9%)
Dec 1990
-
$1.39B(+1.5%)
$283.05M(+235.0%)
Sep 1990
-
$1.37B(-136.3%)
$84.50M(-185.9%)
Jun 1990
$0.00(0.0%)
-$3.78B(-390.9%)
-$98.40M(-112.7%)
Mar 1990
-
$1.30B(+8.8%)
$777.73M(+56.2%)
Dec 1989
-
$1.19B(+0.5%)
$497.95M(+59.5%)
Sep 1989
-
$1.19B(-140.9%)
$312.15M(+117.9%)
Jun 1989
$0.00(0.0%)
-$2.90B(-384.8%)
$143.23M(-67.2%)
Mar 1989
-
$1.02B(+1.1%)
$436.08M(+54.9%)
Dec 1988
-
$1.01B(-1.1%)
$281.52M(+216.2%)
Sep 1988
-
$1.02B(-139.1%)
$89.02M(-232.6%)
Jun 1988
$0.00(0.0%)
-$2.61B(-401.9%)
-$67.13M(-115.3%)
Mar 1988
-
$863.72M(+6.1%)
$437.86M(+51.8%)
Dec 1987
-
$814.42M(-5.5%)
$288.45M(+170.5%)
Sep 1987
-
$862.23M(-141.0%)
$106.62M(-228.7%)
Jun 1987
$0.00(0.0%)
-$2.10B(-394.3%)
-$82.85M(-126.0%)
Mar 1987
-
$714.30M(+12.9%)
$318.48M(+117.8%)
Dec 1986
-
$632.59M(-6.0%)
$146.21M(+135.6%)
Sep 1986
-
$672.76M(-139.5%)
$62.07M(-188.4%)
Jun 1986
$0.00(0.0%)
-$1.70B(-413.8%)
-$70.25M(-104.3%)
Mar 1986
-
$542.04M(-1.2%)
$1.63B(+49.8%)
Dec 1985
-
$548.45M(+1.5%)
$1.09B(+101.5%)
Sep 1985
-
$540.44M
$540.44M
Jun 1985
$0.00(0.0%)
-
-
Jun 1984
$0.00
-
-

FAQ

  • What is GSK annual operating income?
  • What is the all time high annual operating profit for GSK?
  • What is GSK annual operating profit year-on-year change?
  • What is GSK quarterly operating income?
  • What is the all time high quarterly operating profit for GSK?
  • What is GSK quarterly operating profit year-on-year change?
  • What is GSK TTM operating income?
  • What is the all time high TTM operating profit for GSK?
  • What is GSK TTM operating profit year-on-year change?

What is GSK annual operating income?

The current annual operating profit of GSK is $5.14B

What is the all time high annual operating profit for GSK?

GSK all-time high annual operating income is $16.41B

What is GSK annual operating profit year-on-year change?

Over the past year, GSK annual operating income has changed by -$4.00B (-43.77%)

What is GSK quarterly operating income?

The current quarterly operating profit of GSK is $2.79B

What is the all time high quarterly operating profit for GSK?

GSK all-time high quarterly operating income is $13.97B

What is GSK quarterly operating profit year-on-year change?

Over the past year, GSK quarterly operating income has changed by +$900.35M (+47.64%)

What is GSK TTM operating income?

The current TTM operating profit of GSK is $7.95B

What is the all time high TTM operating profit for GSK?

GSK all-time high TTM operating income is $19.27B

What is GSK TTM operating profit year-on-year change?

Over the past year, GSK TTM operating income has changed by -$543.10M (-6.39%)
On this page